SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026)
SS Innovations International (SSII) posted Non-Current Deffered Revenue of $7.5 million for Q1 2026, up 5.06% sequentially from $7.1 million in Q4 2025, and up 38.78% YoY from $5.4 million in Q1 2025.
SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
SS Innovations International has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $7.5 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 38.78% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 38.78% YoY) and the FY2025 annual result came in at $7.1 million, up 38.0% from the prior year.
- Non-Current Deffered Revenue rose to $7.5 million in Q1 2026 per SSII's latest filing, from $7.1 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $7.5 million in Q1 2026 and troughed at $42141.0 in Q4 2022.
- A 5-year average of $3.9 million and a median of $4.3 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2023 and 2025: Non-Current Deffered Revenue jumped 2128.59% in 2023, then jumped 38.0% in 2025.
- Over 5 years, Non-Current Deffered Revenue stood at $42141.0 in 2022, then surged by 2128.59% to $939150.0 in 2023, then jumped by 450.92% to $5.2 million in 2024, then soared by 38.0% to $7.1 million in 2025, then gained by 5.06% to $7.5 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $7.5 million, $7.1 million, and $6.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn | 8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.70 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 7.14 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 939,150.00 |
| Sep 30, 2023 | 796,235.00 |
| Jun 30, 2023 | 348,993.00 |
| Dec 31, 2022 | 42,141.00 |